https://www.qps.com/whitepaper/advancing-early-stage-oncology-drugs-overcoming-trial-challenges/jeanfrancoismaisonApr 41 min readRated NaN out of 5 stars.https://www.qps.com/whitepaper/advancing-early-stage-oncology-drugs-overcoming-trial-challenges/
ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosishttps://pubmed.ncbi.nlm.nih.gov/40467521/
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activityhttps://pubmed.ncbi.nlm.nih.gov/40450523/
Comments